Article Information
History
- July 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andrea Gori1,†,*,
- Uri Obolski2,3,*,
- Todd D. Swarthout1,4,*,
- José Lourenço5,
- Caroline M. Weight1,
- Jen Cornick4,
- Arox Kamng’ona4,6,
- Thandie S. Mwalukomo4,6,
- Jacquline Msefula4,
- Comfort Brown4,
- Martin C. Maiden5,
- Neil French7,
- Sunetra Gupta5 and
- Robert S. Heyderman1
- 1University College London, NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection & Immunity, London, United Kingdom,
- 2Tel-Aviv University, Faculty of Medicine, School of Public Health, Tel Aviv, Israel
- 3Tel-Aviv University, Faculty of Exact Sciences, Porter School of the Environment and Earth Sciences, Tel Aviv, Israel
- 4Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- 5University of Oxford, Department of Zoology, Oxford, United Kingdom
- 6Kamuzu University of Health Sciences, Blantyre, Malawi
- 7University of Liverpool, Clinical Infection, Microbiology and Immunology, Institute of Infection Veterinary & Ecological Science, Liverpool, United Kingdom
- ↵†To whom correspondence should be addressed: a.gori{at}ucl.ac.uk
↵* contributed equally
Posted July 22, 2021.
The metabolic, virulence and antimicrobial resistance profiles of colonizing Streptococcus pneumoniae shift after pneumococcal vaccine introduction in urban Malawi
